This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Will Salesforce.com (CRM) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Salesforce.com (CRM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Want Better Returns? Don?t Ignore These 2 Computer and Technology Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Here is What to Know Beyond Why Salesforce Inc. (CRM) is a Trending Stock
by Zacks Equity Research
Zacks.com users have recently been watching Salesforce.com (CRM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Salesforce.com (CRM) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
Salesforce.com (CRM) closed at $293.77 in the latest trading session, marking a +1.14% move from the prior day.
Should You Bet on Wide Moat Stocks & ETFs Now?
by Sanghamitra Saha
The S&P 500 index has significant concentration risks. If you are worried about it, you can try quality investing like moat stocks and ETFs.
Salesforce.com (CRM) Registers a Bigger Fall Than the Market: Important Facts to Note
by Zacks Equity Research
In the most recent trading session, Salesforce.com (CRM) closed at $288.33, indicating a -1.02% shift from the previous trading day.
Docusign Shares Surge 28% in 3 Months: Right Moment to Invest?
by Shuvra Shankar Dey
With DOCU shares experiencing a significant rally, it's time to assess the stock's current standing and determine whether it remains an attractive investment.
Salesforce Inc. (CRM) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Salesforce.com (CRM). This makes it worthwhile to examine what the stock has in store.
Salesforce.com (CRM) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
The latest trading day saw Salesforce.com (CRM) settling at $290.86, representing a +0.87% change from its previous close.
Salesforce.com (CRM) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
In the most recent trading session, Salesforce.com (CRM) closed at $290.17, indicating a +0.78% shift from the previous trading day.
Oracle (ORCL) Up 11.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Oracle (ORCL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Oracle Launches Investigation Hub: How Should You Play the Stock?
by Zacks Equity Research
ORCL launches the Investigation Hub to enhance client experience and increase efficiency.
EPAM Expands With First Derivative Buyout: What Should Investors Do?
by Zacks Equity Research
Epam Systems expands its AI capabilities in the financial space with the acquisition of First Derivative.
Salesforce Inc. (CRM) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Salesforce.com (CRM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Is Salesforce Stock a Buy, Sell or Hold at a P/E Multiple of 25.96X?
by Anirudha Bhagat
While CRM's slowing growth rates are a concern, its business leadership, acquisitions and push into generative AI provide strong growth potential for the future.
Stock Market News for Oct 3, 2024
by Zacks Equity Research
U.S. stocks closed higher on Wednesday as investors reacted to stronger-than-expected private sector job gains and anticipated further Federal Reserve interest rate cuts in November.
Should You Invest in the iShares Expanded Tech-Software Sector ETF (IGV)?
by Zacks Equity Research
Sector ETF report for IGV
Why Is Salesforce.com (CRM) Up 7.3% Since Last Earnings Report?
by Zacks Equity Research
Salesforce.com (CRM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
If You Invested $1000 in Salesforce.com a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Nice Launches AI Fraud Solution: How Should Investors Play the Stock?
by Zacks Equity Research
NICE Actimize launches the first AI-powered Fraud Investigations solution, streamlining fraud management and enhancing efficiency for financial institutions.
Investors Heavily Search Salesforce Inc. (CRM): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Salesforce.com (CRM). This makes it worthwhile to examine what the stock has in store.
The Zacks Analyst Blog Highlights NVIDIA, Salesforce, Alphabet, Microsoft and AMD
by Zacks Equity Research
NVIDIA, Salesforce, Alphabet, Microsoft and AMD are part of the Zacks top Analyst blog.
Post-Fed Rate Cut: Buy, Hold, or Sell NVIDIA Stock?
by Tirthankar Chakraborty
NVIDIA stock always performs well after interest rate cuts and gets access to cheaper capital. Time to Buy?
The Zacks Analyst Blog Exxon Mobil, Salesforce, BHP and Oil-Dri
by Zacks Equity Research
Exxon Mobil, Salesforce, BHP and Oil-Dri are included in this Analyst Blog.
Top Analyst Reports for Exxon Mobil, Salesforce & BHP
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corp. (XOM), Salesforce, Inc. (CRM) and BHP Group Ltd. (BHP), as well as a micro-cap stock Oil-Dri Corporation of America (ODC).